ArticleJACS Au2025
Article in JACS Au, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Toward Rational Design of Precision-Fermented Milk Proteins: Integrating Cross-Species Selection, Post-Translational Modification, and AI Optimization.Comprehensive reviews in food science and food safety · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The rational design of signal peptides represents a fundamental bottleneck in biotechnology, where sequence optimization directly governs protein secretion efficiency and industrial scalability. Current approaches rely predominantly on natural variants or empirical mutations, constraining the accessible sequence space and limiting performance gains. Here, we develop the SPgo computational framework, which overcomes these limitations by combining rule-based domain assembly with a Transformer-enabled deep generative model to support the design of Sec-type signal peptides. Our hybrid architecture constructs optimal N- and C-terminal regions through biophysical constraints while deploying a BERT-LSTM pipeline to explore vast sequence landscapes within the critical hydrophobic core. Rigorous validation of a variety of protein targets, from fluorescent proteins to industrial enzymes and bioactive peptides, showed that SPgo-designed sequences consistently outperformed natural sequences. Most notably, SPgo was able to achieve secretory production of snake venom peptides at an unprecedented yield of 154 mg/L, a 150-fold increase in target protein yield per unit culture volume compared to traditional intracellular expression, transforming previously intractable targets into viable biotechnology platforms. This work establishes a new paradigm for computational protein design, offering immediate applications in biomanufacturing while revealing the untapped potential of artificial sequence space to surpass natural evolutionary solutions. The SPgo framework data can be found on github (https://github.com/lzlinn801/SPgo).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.